https://assets.capyfin.com/instruments/678fdc13234e27009c5d5879.png avatar
DaVita
🇺🇸 NYSE:DVA
View Company
OverviewEarningsDividends
•
Dec 31, 2022

DaVita Q4 2022 Earnings Report

DaVita's financial performance for Q4 2022 reflected revenue of $2.917 billion and EPS of $0.59.

Key Takeaways

DaVita Inc. reported consolidated revenues of $2.917 billion for the three months ended December 31, 2022. The diluted earnings per share from continuing operations was $0.59, and the adjusted diluted earnings per share from continuing operations was $1.11 for the same period. Operating income was $256 million, with an adjusted operating income of $317 million.

Consolidated revenues reached $2.917 billion.

Operating income amounted to $256 million, while adjusted operating income was $317 million.

Diluted earnings per share from continuing operations stood at $0.59, with adjusted diluted earnings per share at $1.11.

Operating cash flow was $344 million, and free cash flow was $75 million.

Total Revenue
$2.92B
Previous year: $2.94B
-0.9%
EPS
$1.11
Previous year: $2.02
-45.0%
US Dialysis Treatments
7.24M
Previous year: 7.46M
-2.9%
US Avg Treatments per day
91.64K
Previous year: 94.37K
-2.9%
US Revenue per Treatment
$366
Previous year: $362
+1.3%
Gross Profit
$828M
Previous year: $884M
-6.3%
Cash and Equivalents
$244M
Previous year: $462M
-47.2%
Free Cash Flow
$75M
Previous year: $290M
-74.1%
Total Assets
$16.9B
Previous year: $17.1B
-1.1%

DaVita

DaVita

DaVita Revenue by Segment

DaVita Revenue by Geographic Location

Forward Guidance

DaVita anticipates adjusted operating income from continuing operations to be between $1.4 billion and $1.6 billion, and adjusted diluted net income from continuing operations per share attributable to DaVita Inc. to be between $5.45 and $6.95. The company expects free cash flow to range from $650 million to $900 million for 2023.

Positive Outlook

  • Expected adjusted operating income from continuing operations between $1.4 billion and $1.6 billion.
  • Anticipated adjusted diluted net income from continuing operations per share attributable to DaVita Inc. between $5.45 and $6.95.
  • Projected free cash flow between $650 million and $900 million.
  • Focus on differentiating DaVita as a healthcare provider and employer of choice.
  • Excitement and conviction in the long-term capabilities and strategy.

Challenges Ahead

  • Guidance excludes certain items, including capacity closure charges and severance costs, which may be significant.
  • Guidance excludes foreign currency fluctuations, which may be significant.
  • Uncertainty related to the widespread impact of the COVID-19 pandemic.
  • Challenges in the labor environment are expected to persist in 2023.
  • Continued monitoring of volume and the labor environment due to ongoing challenges.

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Company Overview

Full financial data and analysis

View DaVita